Translation of basic science into clinical medicine: novel targets for diabetic nephropathy.
Miyata
Toshio
T
van Ypersele de Strihou
Charles
C
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000818:Animals; D035843:Biomedical Research / Q000639:trends*; D015510:Clinical Medicine / Q000639:trends*; D003928:Diabetic Nephropathies / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy*; D004195:Disease Models, Animal; D006801:Humans; D006943:Hyperglycemia / Q000150:complications / Q000188:drug therapy; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D051379:Mice; D009765:Obesity / Q000150:complications / Q000178:diet therapy; D000077205:Pioglitazone; D017395:Plasminogen Activator Inhibitor 1 / Q000235:genetics; D051381:Rats; D011918:Rats, Inbred SHR; D045162:Thiazolidinediones
D047228:Angiotensin II Type 1 Receptor Blockers; D017395:Plasminogen Activator Inhibitor 1; D045162:Thiazolidinediones; D000077205:Pioglitazone